{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:23:37Z","timestamp":1787027017775,"version":"build-2736575974"},"reference-count":114,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T00:00:00Z","timestamp":1537315200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010221","name":"Higher Education Commision, Pakistan","doi-asserted-by":"publisher","award":["112-34421-2BM1-428"],"award-info":[{"award-number":["112-34421-2BM1-428"]}],"id":[{"id":"10.13039\/501100010221","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2018.01035","type":"journal-article","created":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T10:50:49Z","timestamp":1537354249000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":45,"title":["Experimentally Validated Pharmacoinformatics Approach to Predict hERG Inhibition Potential of New Chemical Entities"],"prefix":"10.3389","volume":"9","author":[{"given":"Saba","family":"Munawar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique J.","family":"Windley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin G.","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew H.","family":"Todd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam P.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie I.","family":"Vandenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishrat","family":"Jabeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,9,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2174\/157488610789869265","article-title":"QT alterations in psychopharmacology: proven candidates and suspects","volume":"5","author":"Alvarez","year":"2010","journal-title":"Curr. Drug Saf."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1021\/acs.jcim.8b00124","article-title":"Multi-descriptor read across (MuDRA): a simple and transparent approach for developing accurate QSAR models","volume":"58","author":"Alves","year":"2018","journal-title":"J Chem Inf Model."},{"key":"B3","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S1359-6446(04)03278-7","article-title":"Predictive in silico modeling for hERG channel blockers","volume":"10","author":"Aronov","year":"2005","journal-title":"Drug Discov. Today"},{"key":"B4","doi-asserted-by":"publisher","first-page":"6917","DOI":"10.1021\/jm060500o","article-title":"Common pharmacophores for uncharged human ether-a-go-go-related gene (hERG) blockers","volume":"49","author":"Aronov","year":"2006","journal-title":"J. Med. Chem."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1016\/j.bmc.2004.02.003","article-title":"A model for identifying HERG K+ channel blockers","volume":"12","author":"Aronov","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"B6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.pbiomolbio.2003.09.001","article-title":"HERG binding specificity and binding site structure: evidence from a fragment-based evolutionary computing SAR study","volume":"86","author":"Bains","year":"2004","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/qsar.19930120103","article-title":"Generating optimal linear PLS estimations (GOLPE): an advanced chemometric tool for handling 3D-QSAR problems","volume":"12","author":"Baroni","year":"1993","journal-title":"Quant. Struct. Act. Relat."},{"key":"B8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0165-0270(94)90031-0","article-title":"JPCalc, a software package for calculating liquid junction potential corrections in patch-clamp, intracellular, epithelial and bilayer measurements and for correcting junction potential measurements","volume":"51","author":"Barry","year":"1994","journal-title":"J. Neurosci. Methods"},{"key":"B9","doi-asserted-by":"publisher","first-page":"D1083","DOI":"10.1093\/nar\/gkt1031","article-title":"The ChEMBL bioactivity database: an update","volume":"42","author":"Bento","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0014-2999(00)00693-2","article-title":"Effects of fluoroquinolones on HERG currents","volume":"406","author":"Bischoff","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"5039","DOI":"10.1021\/jm0704651","article-title":"Influence of conformation on GRIND-based three-dimensional quantitative structure\u2013activity relationship (3D-QSAR)","volume":"50","author":"Caron","year":"2007","journal-title":"J. Med. Chem."},{"key":"B12","doi-asserted-by":"publisher","first-page":"3844","DOI":"10.1021\/jm0208875","article-title":"Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K+ channel blockers","volume":"45","author":"Cavalli","year":"2002","journal-title":"J. Med. Chem."},{"key":"B13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1089\/adt.2006.4.73","article-title":"Evaluation of the rubidium efflux assay for preclinical identification of HERG blockade","volume":"4","author":"Chaudhary","year":"2006","journal-title":"Assay Drug Dev. Technol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10822-016-9898-z","article-title":"A k-nearest neighbor classification of hERG K+ channel blockers","volume":"30","author":"Chavan","year":"2016","journal-title":"J. Comput. Aided Mol. Des."},{"key":"B15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fchem.2017.00007","article-title":"Computational tool for fast in silico evaluation of hERG K+ channel affinity","volume":"5","author":"Chemi","year":"2017","journal-title":"Front. Chem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1254\/jphs.FPE0040101","article-title":"Validation of a [3H] astemizole binding assay in HEK293 cells expressing HERG K+ channels","volume":"95","author":"Chiu","year":"2004","journal-title":"J. Pharmacol. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.bbrc.2006.03.146","article-title":"A novel hypothesis for the binding mode of HERG channel blockers","volume":"344","author":"Choe","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1016\/j.ejmech.2007.12.025","article-title":"Identification of toxicophoric features for predicting drug-induced QT interval prolongation","volume":"43","author":"Coi","year":"2008","journal-title":"Eur. J. Med. Chem."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s11095-006-0070-7","article-title":"Effects of antipsychotic drugs on Ito, INa, Isus, IK1, and hERG: QT prolongation, structure activity relationship, and network analysis","volume":"23","author":"Crumb","year":"2006","journal-title":"Pharm. Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.vascn.2016.03.009","article-title":"An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel","volume":"81","author":"Crumb","year":"2016","journal-title":"J. Pharm. Toxicol. Methods"},{"key":"B21","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1093\/eurheartj\/ehi092","article-title":"Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death","author":"De Bruin","year":"2005","journal-title":"Eur. Heart J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2165\/00002018-200225040-00004","article-title":"Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes","volume":"25","author":"De Ponti","year":"2002","journal-title":"Drug Saf."},{"key":"B23","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1021\/ci400707h","article-title":"Assessing hERG pore models as templates for drug docking using published experimental constraints: the inactivated state in the context of drug block","volume":"54","author":"Dempsey","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"B24","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/cmdc.200500099","article-title":"In silico classification of hERG channel blockers: a knowledge-based strategy","volume":"1","author":"Dubus","year":"2006","journal-title":"ChemMedChem"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.1021\/ci200271d","article-title":"A critical assessment of combined ligand-and structure-based approaches to HERG channel blocker modeling","volume":"51","author":"Du-Cuny","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"B26","volume-title":"Development of High-Performance Algorithms for a New Generation of Versatile Molecular Descriptors","author":"Dur\u00e1n Alcaide","year":"2010"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1021\/ci800037t","article-title":"Development and validation of AMANDA, a new algorithm for selecting highly relevant regions in molecular interaction fields","volume":"48","author":"Dur\u00e1n","year":"2008","journal-title":"J. Chem. Inf. Model."},{"key":"B28","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1021\/ci100409y","article-title":"Combined receptor and ligand-based approach to the universal pharmacophore model development for studies of drug blockade to the hERG1 pore domain","volume":"51","author":"Durdagi","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"B29","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1124\/jpet.301.2.427","article-title":"Three-dimensional quantitative structure-activity relationship for inhibition of human ether-a-go-go-related gene potassium channel","volume":"301","author":"Ekins","year":"2002","journal-title":"J. Pharm. Exp. Ther."},{"key":"B30","first-page":"111","article-title":"Leave-one-out error and stability of learning algorithms with applications","volume":"190","author":"Elisseeff","year":"2003","journal-title":"NATO Science Series Sub Series III Comput. Syst. Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1016\/j.bmc.2005.12.032","article-title":"New insights about HERG blockade obtained from protein modeling, potential energy mapping, and docking studies","volume":"14","author":"Farid","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"B32","doi-asserted-by":"publisher","first-page":"4371","DOI":"10.1021\/ja00194a034","article-title":"A new approach to probing conformational space with molecular mechanics: random incremental pulse search","volume":"111","author":"Ferguson","year":"1989","journal-title":"J. Am. Chem. Soc."},{"key":"B33","doi-asserted-by":"publisher","first-page":"10120","DOI":"10.1074\/jbc.M310683200","article-title":"Physicochemical features of the HERG channel drug binding site","volume":"279","author":"Fernandez","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B34","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0014-2999(01)01362-0","article-title":"[3 H] Dofetilide binding to HERG transfected membranes: a potential high throughput preclinical screen","volume":"430","author":"Finlayson","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"B35","first-page":"36791","article-title":"International Conference on Harmonisation; guidance on S7A safety pharmacology studies for human pharmaceuticals; availability. Notice","volume":"66","author":"Food and Drug Administration","year":"2001","journal-title":"Fed. Regist."},{"key":"B36","first-page":"61134","article-title":"International Conference on Harmonisation; guidance on E14 clinical evaluation of QT\/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs; availability. Notice","volume":"70","author":"Food and Drug Administration","year":"","journal-title":"Fed. Regist."},{"key":"B37","first-page":"61133","article-title":"International Conference on Harmonisation; guidance on S7B nonclinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals; availability. Notice","volume":"70","author":"Food and Drug Administration","year":"","journal-title":"Fed. Regist."},{"key":"B38","doi-asserted-by":"publisher","first-page":"113","DOI":"10.4155\/fmc.12.208","article-title":"Lipophilic efficiency: the most important efficiency metric in medicinal chemistry","volume":"5","author":"Freeman-Cook","year":"2013","journal-title":"Fut. Med. Chem."},{"key":"B39","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.jmgm.2007.08.002","article-title":"Exploring QSTR and toxicophore of hERG K+ channel blockers using GFA and HypoGen techniques","volume":"26","author":"Garg","year":"2008","journal-title":"J. Mol. Graph. Model."},{"key":"B40","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/0898-5529(90)90156-3","article-title":"Automatic generation of 3D-atomic coordinates for organic molecules","volume":"3","author":"Gasteiger","year":"1990","journal-title":"Tetrahedron Comput. Methodol."},{"key":"B41","volume-title":"Practical Optimization","author":"Gill","year":"1981"},{"key":"B42","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1021\/jm701122q","article-title":"Generation of a set of simple, interpretable ADMET rules of thumb","volume":"51","author":"Gleeson","year":"2008","journal-title":"J. Med. Chem."},{"key":"B43","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1107\/S2052520616003954","article-title":"The Cambridge structural database","volume":"72","author":"Groom","year":"2016","journal-title":"Acta Crystallogr. Sect. B Struct. Sci. Cryst. Eng. Mater."},{"key":"B44","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/toxsci\/kfm026","article-title":"Preclinical cardiovascular risk assessment in modern drug development","volume":"97","author":"Guth","year":"2007","journal-title":"Toxicol. Sci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/(SICI)1096-987X(199604)17:5\/6<490::AID-JCC1>3.0.CO;2-P","article-title":"Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94","volume":"17","author":"Halgren","year":"1996","journal-title":"J. Comput. Chem."},{"key":"B46","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/BF00656997","article-title":"Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches","volume":"391","author":"Hamill","year":"1981","journal-title":"Pfl\u00fcgers Archiv Eur. J. Physiol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.pharmthera.2008.05.009","article-title":"The hERG potassium channel and hERG screening for drug-induced torsades de pointes","volume":"119","author":"Hancox","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"B48","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1124\/mol.114.091835","article-title":"Kinetics of drug interaction with the Kv11. 1 potassium channel","volume":"85","author":"Hill","year":"2014","journal-title":"Mol. Pharmacol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/S.1359-6446(04)03069-7","article-title":"Ligand efficiency: a useful metric for lead selection","volume":"9","author":"Hopkins","year":"2004","journal-title":"Drug Discov. Today"},{"key":"B50","volume-title":"Molecular Operating Environment (MOE)","author":"I","year":"2013"},{"key":"B51","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1021\/jm201705f","article-title":"Structure\u2013activity relationships, ligand efficiency, and lipophilic efficiency profiles of benzophenone-type inhibitors of the multidrug transporter P-glycoprotein","volume":"55","author":"Jabeen","year":"2012","journal-title":"J. Med. Chem."},{"key":"B52","doi-asserted-by":"publisher","first-page":"6182","DOI":"10.1016\/j.bmc.2007.06.028","article-title":"Estimation of hERG inhibition of drug candidates using multivariate property and pharmacophore SAR","volume":"15","author":"Johnson","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"B53","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1161\/01.RES.72.1.75","article-title":"Rate-dependent prolongation of cardiac action potentials by a methanesulfonanilide class III antiarrhythmic agent. Specific block of rapidly activating delayed rectifier K+ current by dofetilide","volume":"72","author":"Jurkiewicz","year":"1993","journal-title":"Circ. Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/med.21445","article-title":"Development of safe drugs: the hERG challenge","volume":"38","author":"Kalyaanamoorthy","year":"2017","journal-title":"Med. Res. Rev."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1016\/S0960-894X(03)00492-X","article-title":"Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods","volume":"13","author":"Keser\u00fc","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B56","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1590\/S0103-50532009000400021","article-title":"Basic validation procedures for regression models in QSAR and QSPR studies: theory and application","volume":"20","author":"Kiralj","year":"2009","journal-title":"J. Braz. Chem. Soc."},{"key":"B57","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1080\/1062936X.2012.742135","article-title":"Towards in silico identification of the human ether-a-go-go-related gene channel blockers: discriminative vs. generative classification models. SAR and QSAR","volume":"24","author":"Kireeva","year":"2013","journal-title":"Environ. Res."},{"key":"B58","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/cmdc.200700221","article-title":"A composite model for hERG blockade","volume":"3","author":"Kramer","year":"2008","journal-title":"ChemMedChem"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1021\/ci5001955","article-title":"Experimentally validated hERG pharmacophore models as cardiotoxicity prediction tools","volume":"54","author":"Kratz","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"B60","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.pbiomolbio.2015.12.005","article-title":"In silico assessment of kinetics and state dependent binding properties of drugs causing acquired LQTS","volume":"120","author":"Lee","year":"2016","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"B61","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0026-895X(24)23209-0","article-title":"Molecular determinant of high-affinity dofetilide binding toHERG1 expressed in Xenopus oocytes: involvement of S6 sites","volume":"57","author":"Lees-Miller","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/nrd2445","article-title":"The influence of drug-like concepts on decision-making in medicinal chemistry","volume":"6","author":"Leeson","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"B63","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1021\/mp700124e","article-title":"hERG classification model based on a combination of support vector machine method and GRIND descriptors","volume":"5","author":"Li","year":"2008","journal-title":"Mol. Pharm."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1700074","DOI":"10.1002\/minf.201700074","article-title":"Modeling of the hERG K+ channel blockage using online chemical database and modeling environment (OCHEM)","volume":"36","author":"Li","year":"2017","journal-title":"Mol. Inf."},{"key":"B65","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.addr.2012.09.019","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"64","author":"Lipinski","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/aps.2014.35","article-title":"Novel Bayesian classification models for predicting compounds blocking hERG potassium channels","volume":"35","author":"Liu","year":"2014","journal-title":"Acta Pharmacol. Sin."},{"key":"B67","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/978-1-4939-7717-8_15","article-title":"Machine learning-based modeling of drug toxicity","author":"Lu","year":"2018","journal-title":"Comput. Syst. Biol."},{"key":"B68","volume-title":"Molecular Interaction Fields: Applications in Drug Discovery and ADME Prediction","author":"Mannhold","year":"2006"},{"key":"B69","first-page":"667","article-title":"Molecular determinants of high-affinity drug binding to HERG channels","volume":"6","author":"Mitcheson","year":"2003","journal-title":"Curr. Opin. Drug Discov. Dev."},{"key":"B70","doi-asserted-by":"publisher","first-page":"12329","DOI":"10.1073\/pnas.210244497","article-title":"A structural basis for drug-induced long QT syndrome","volume":"97","author":"Mitcheson","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/0140-6736(93)92412-M","article-title":"Cardiac effects of antimalarial treatment with halofantrine","volume":"341","author":"Nosten","year":"1993","journal-title":"Lancet"},{"key":"B72","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1021\/jm000941m","article-title":"GRid-INdependent descriptors (GRIND): a novel class of alignment-independent three-dimensional molecular descriptors","volume":"43","author":"Pastor","year":"2000","journal-title":"J. Med. Chem."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/S0960-894X(03)00196-3","article-title":"Characterization of HERG potassium channel inhibition using CoMSiA 3D QSAR and homology modeling approaches","volume":"13","author":"Pearlstein","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1124\/mol.108.049056","article-title":"Drug binding to the inactivated state is necessary but not sufficient for high-affinity binding to human ether-a-go-go-related gene channels","volume":"74","author":"Perrin","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/jat.1395","article-title":"Collation, assessment and analysis of literature in vitro data on hERG receptor blocking potency for subsequent modeling of drugs' cardiotoxic properties","volume":"29","author":"Polak","year":"2009","journal-title":"J. Appl. Toxicol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1517\/17425250903055070","article-title":"hERG-related drug toxicity and models for predicting hERG liability and QT prolongation","volume":"5","author":"Raschi","year":"2009","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.phrs.2008.01.009","article-title":"The hERG K+ channel: target and antitarget strategies in drug development","volume":"57","author":"Raschi","year":"2008","journal-title":"Pharmacol. Res."},{"key":"B78","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0008-6363(02)00846-5","article-title":"Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development","volume":"58","author":"Redfern","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"B79","doi-asserted-by":"publisher","first-page":"4258","DOI":"10.1016\/j.bmcl.2007.05.038","article-title":"The role of molecular size in ligand efficiency","volume":"17","author":"Reynolds","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1056\/NEJMra032426","article-title":"Drug-induced prolongation of the QT interval","volume":"350","author":"Roden","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/0002-8703(86)90010-4","article-title":"Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care","volume":"111","author":"Roden","year":"1986","journal-title":"Am. Heart J."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1124\/mol.63.5.1051","article-title":"Voltage-dependent profile of humanether-a-go-go-related gene channel block is influenced by a single residue in the S6 transmembrane domain","volume":"63","author":"S\u01cenchez-Chapula","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/0092-8674(95)90340-2","article-title":"A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channel","volume":"81","author":"Sanguinetti","year":"1995","journal-title":"Cell"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1161\/CIRCULATIONAHA.111.080887","article-title":"Clinical and genetic determinants of torsade de pointes risk","volume":"125","author":"Sauer","year":"2012","journal-title":"Circulation"},{"key":"B85","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.1747-0285.2006.00379.x","article-title":"A QSAR model of hERG binding using a large, diverse, and internally consistent training set","volume":"67","author":"Seierstad","year":"2006","journal-title":"Chem. Biol. Drug Des."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1021\/jm070543k","article-title":"Overcoming undesirable HERG potency of chemokine receptor antagonists using baseline lipophilicity relationships","volume":"51","author":"Shamovsky","year":"2008","journal-title":"J. Med. Chem."},{"key":"B87","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1021\/jm050540c","article-title":"Novel procedure for modeling ligand\/receptor induced fit effects","volume":"49","author":"Sherman","year":"2006","journal-title":"J. Med. Chem."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1021\/acs.jcim.8b00150","article-title":"The Catch-22 of predicting hERG blockade using publicly accessible bioactivity data","volume":"58","author":"Siramshetty","year":"2018","journal-title":"J. Chem. Inf. Model."},{"key":"B89","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1021\/ci050308f","article-title":"Development and evaluation of an in silico model for hERG binding","volume":"46","author":"Song","year":"2006","journal-title":"J. Chem. Inf. Model."},{"key":"B90","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/prot.21400","article-title":"Drug block of the hERG potassium channel: insight from modeling","volume":"68","author":"Stansfeld","year":"2007","journal-title":"Proteins Struct. Funct. Bioinf."},{"key":"B91","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jmgm.2017.01.012","article-title":"3D-SDAR modeling of hERG potassium channel affinity: a case study in model design and toxicophore identification","volume":"72","author":"Stoyanova-Slavova","year":"2017","journal-title":"J. Mol. Graph. Model."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1021\/ci100081j","article-title":"In silico binary classification QSAR models based on 4D-fingerprints and MOE descriptors for prediction of hERG blockage","volume":"50","author":"Su","year":"2010","journal-title":"J. Chem. Inf. Model."},{"key":"B93","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/cmdc.200500047","article-title":"An accurate and interpretable Bayesian classification model for prediction of hERG liability","volume":"1","author":"Sun","year":"2006","journal-title":"ChemMedChem"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1600126","DOI":"10.1002\/minf.201600126","article-title":"Prediction of hERG liability\u2013using SVM classification, bootstrapping and jackknifing","volume":"36","author":"Sun","year":"2017","journal-title":"Mol. Inf."},{"key":"B95","doi-asserted-by":"publisher","first-page":"4587","DOI":"10.1016\/j.bmcl.2013.06.034","article-title":"Are hERG channel blockers also phospholipidosis inducers?","volume":"23","author":"Sun","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s00894-011-1136-y","article-title":"Predicting the potency of hERG K+ channel inhibition by combining 3D-QSAR pharmacophore and 2D-QSAR models","volume":"18","author":"Tan","year":"2012","journal-title":"J. Mol. Model."},{"key":"B97","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1177\/108705710100600506","article-title":"Development and evaluation of high throughput functional assay methods for HERG potassium channel","volume":"6","author":"Tang","year":"2001","journal-title":"J. Biomol. Screening"},{"key":"B98","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.2174\/0929867043364351","article-title":"Torsadogenic cardiotoxicity of antipsychotic drugs: a structural feature, potentially involved in the interaction with cardiac HERG potassium channels","volume":"11","author":"Testai","year":"2004","journal-title":"Curr. Med. Chem."},{"key":"B99","doi-asserted-by":"publisher","first-page":"4107","DOI":"10.1016\/j.bmc.2008.01.017","article-title":"A binary QSAR model for classification of hERG potassium channel blockers","volume":"16","author":"Thai","year":"","journal-title":"Bioorg. Med. Chem."},{"key":"B100","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/j.1747-0285.2008.00705.x","article-title":"Classification Models for hERG inhibitors by counter-propagation neural networks","volume":"72","author":"Thai","year":"","journal-title":"Chem. Biol. Drug Des."},{"key":"B101","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.tips.2017.06.004","article-title":"Towards a structural view of drug binding to hERG K+ channels","volume":"38","author":"Vandenberg","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1152\/physrev.00036.2011","article-title":"hERG K+ channels: structure, function, and clinical significance","volume":"92","author":"Vandenberg","year":"2012","journal-title":"Physiol. Rev."},{"key":"B103","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.comtox.2017.05.001","article-title":"Performance of machine learning algorithms for qualitative and quantitative prediction drug blockade of hERG1 channel","volume":"6","author":"Wacker","year":"2018","journal-title":"Comput. Toxicol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/sj.bjp.0702774","article-title":"Inhibition of the human ether-a-go-go-related gene (HERG) potassium channel by cisapride: affinity for open and inactivated states","volume":"128","author":"Walker","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1021\/acs.molpharmaceut.6b00471","article-title":"ADMET evaluation in drug discovery. 16. Predicting hERG blockers by combining multiple pharmacophores and machine learning approaches","volume":"13","author":"Wang","year":"2016","journal-title":"Mol. Pharm."},{"key":"B106","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.cell.2017.03.048","article-title":"Cryo-EM structure of the open human ether-\u00e0-go-go-related K+ channel hERG","volume":"169","author":"Wang","year":"2017","journal-title":"Cell"},{"key":"B107","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1021\/acscentsci.6b00086","article-title":"Open source drug discovery: highly potent antimalarial compounds derived from the tres cantos arylpyrroles","volume":"2","author":"Williamson","year":"2016","journal-title":"ACS Cent. Sci."},{"key":"B108","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1124\/mol.117.111534","article-title":"The temperature dependence of kinetics associated with drug block of hERG channels are compound specific and an important factor for proarrhythmic risk prediction","volume":"94","author":"Windley","year":"2018","journal-title":"Mol. Pharmacol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0169-7439(87)80084-9","article-title":"Principal component analysis","volume":"2","author":"Wold","year":"1987","journal-title":"Chemometr. Intell. Lab. Syst."},{"key":"B110","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1111\/j.1440-1681.2009.05150.x","article-title":"HERG-F463L potassium channels linked to long QT syndrome reduce IKr current by a trafficking-deficient mechanism","volume":"36","author":"Yang","year":"2009","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1021\/ci050450g","article-title":"Quantitative structure\u2013 activity relationship studies on inhibition of hERG potassium channels","volume":"46","author":"Yoshida","year":"2006","journal-title":"J. Chem. Inf. Model."},{"key":"B112","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/1440-1681.12028","article-title":"L539 fs\/47, a truncated mutation of human ether-a-go-go-related gene (hERG), decreases hERG ion channel currents in HEK 293 cells","volume":"40","author":"Zhang","year":"2013","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1111\/j.1540-8167.1999.tb00264.x","article-title":"Block of HERG potassium channels by the antihistamine astemizole and its metabolites desmethylastemizole and norastemizole","volume":"10","author":"Zhou","year":"1999","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1021\/tx800252e","article-title":"Promises and pitfalls of quantitative structure\u2013activity relationship approaches for predicting metabolism and toxicity","volume":"21","author":"Zvinavashe","year":"2008","journal-title":"Chem. Res. Toxicol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.01035\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T17:59:07Z","timestamp":1751911147000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.01035\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,19]]},"references-count":114,"alternative-id":["10.3389\/fphar.2018.01035"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2018.01035","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,19]]},"article-number":"1035"}}